IONQ 8-K
IonQ, Inc. (IONQ)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): |
(Exact name of Registrant as Specified in Its Charter)
(State or Other Jurisdiction |
(Commission File Number) |
(IRS Employer |
||
|
|
|
|
|
|
||||
|
||||
(Address of Principal Executive Offices) |
|
(Zip Code) |
||
Registrant’s Telephone Number, Including Area Code: |
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Securities registered pursuant to Section 12(b) of the Act:
|
|
Trading |
|
|
|
|
|||
|
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 3.02 Unregistered Sales of Equity Securities.
On March 11, 2026, IonQ, Inc. (the “Company”) filed with the Securities and Exchange Commission (the “SEC”) a prospectus supplement to the prospectus included in the Company’s Registration Statement on Form S-3ASR filed with the SEC on February 26, 2025 (File No. 333-285279) (the “Registration Statement”), covering the resale by the selling stockholder of an aggregate of 2,562,642 shares of Company common stock, par value $0.0001 per share. The prospectus supplement was filed in accordance with a Registration Rights Agreement, dated March 10, 2026, by and between the Company and The Chancellor, Masters, and Scholars of the University of Cambridge (the “Registration Rights Agreement”). The foregoing description of the Registration Rights Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of such Registration Rights Agreement, a copy of which is filed as Exhibit 4.1 hereto and is incorporated by reference herein. A copy of the legal opinion of Paul, Weiss, Rifkind, Wharton & Garrison LLP relating to the shares covered by the prospectus supplement is filed herewith as Exhibit 5.1, and is filed with reference to, and is hereby incorporated by reference into, the Registration Statement. The issuance of shares of common stock of the Company, par value $0.0001 per share, in connection with the transaction was made in reliance on the private offering exemption of Section 4(a)(2) of the Securities Act of 1933, as amended, and/or the private offering provision of Rule 506 of Regulation D.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
Exhibit |
|
Description |
4.1 |
|
Registration Rights Agreement, dated as of March 10, 2026, by and between IonQ, Inc. and The Chancellor, |
|
|
|
5.1 |
|
|
|
|
|
23.1 |
|
Consent of Paul, Weiss, Rifkind, Wharton & Garrison LLP (included in Exhibit 5.1). |
|
|
|
104 |
|
Cover Page Interactive Data File (embedded within the Inline XBRL document) |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
IonQ, Inc. |
|
|
|
|
Date: |
March 11, 2026 |
By: |
/s/ Paul T. Dacier |
|
|
|
Paul T. Dacier |
Execution Version
REGISTRATION RIGHTS AGREEMENT
This REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is made and entered into 10 March, 2026 and effective as of 10 March, 2026 by and between IonQ, Inc., a Delaware corporation (“IonQ”) and the undersigned (the “Holder”).
RECITALS
WHEREAS, IonQ and the Holder are parties to that Collaboration Agreement dated the date hereof (as may be amended, restated or modified from time to time, the “Collaboration Agreement”), pursuant to which IonQ is issuing 2,562,642 shares of common stock, par value $0.0001, of IonQ (“IonQ Common Stock”) to the Holder.
NOW, THEREFORE, in consideration of the covenants and other agreements of each Party contained herein, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged and accepted, the parties hereto hereby agree as follows:
2
3
4
5
6
7
[Remainder of Page Intentionally Left Blank]
8
In Witness Whereof, the parties hereto have executed this Agreement as of the date first above written.
IONQ, INC.
By: /s/ Niccolo de Masi
Name: Niccolo de Masi
Title: Chairman & CEO
THE CHANCELLOR, MASTERS, AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE
By: /s/ Professor Sir John Aston
Name: Professor Sir John Aston
Title: Pro-Vice-Chancellor for Research
Paul, Weiss, Rifkind, Wharton & Garrison LLP |
Brussels |
1285 Avenue of the Americas |
March 11, 2026
IonQ, Inc.
4505 Campus Drive
College Park, MD 20740
Registration Statement on Form S-3ASR
(Registration No. 333-285279)
Ladies and Gentlemen:
We have acted as special counsel to IonQ, Inc., a Delaware corporation (the “Company”), in connection with the registration statement on Form S-3ASR (File No. 333–285279) (the “Registration Statement”), which became effective on February 26, 2025. You have asked us to furnish our opinion as to the legality of up to 2,562,642 shares (the “Shares”) of common stock of the Company, par value $0.0001 per share, which are being registered under the Registration Statement and may be offered and sold by certain stockholders of the Company.
In connection with the furnishing of this opinion, we have examined originals, or copies certified or otherwise identified to our satisfaction, of the following documents:
IonQ, Inc. 2
In addition, we have examined (i) such corporate records of the Company that we have considered appropriate, including a copy of the certificate of incorporation, as amended, and bylaws, as amended, of the Company certified by the Company as in effect on the date of this letter, (ii) copies of resolutions of the board of directors of the Company relating to the issuance of the Shares, certified by the Company and (iii) such other certificates, agreements and documents as we deemed relevant and necessary as a basis for the opinions expressed below. We have also relied upon oral and written statements of officers and representatives of the Company as to factual matters and upon certificates of public officials and the officers of the Company.
In our examination of the documents referred to above, we have assumed, without independent investigation, the genuineness of all signatures, the legal capacity of all individuals who have executed any of the documents reviewed by us, the authenticity of all documents submitted to us as originals, the conformity to the originals of all documents submitted to us as certified, photostatic, reproduced or conformed copies of valid existing agreements or other documents, the authenticity of all such latter documents and that the statements regarding matters of fact in the certificates, records, agreements, instruments and documents that we have examined are accurate and complete.
Based upon the above, and subject to the stated assumptions, exceptions and qualifications, we are of the opinion that the Shares have been duly authorized by all necessary
IonQ, Inc. 3
corporate action on the part of the Company and the Shares are validly issued, fully paid and non-assessable.
The opinion expressed above is limited to the Delaware General Corporation Law. Our opinion is rendered only with respect to the laws, and the rules, regulations and orders under those laws, that are currently in effect.
We hereby consent to use of this opinion as an exhibit to the Company’s Current Report on Form 8-K filed by the Company with the Securities and Exchange Commission (the “Commission”) on the date hereof, and to the use of our name under the heading “Legal Matters” in the Prospectus Supplement. In giving this consent, we do not thereby admit that we come within the category of persons whose consent is required by the Securities Act of 1933, as amended, or the rules and regulations of the Commission thereunder.
Very truly yours,
/s/ PAUL, WEISS, RIFKIND, WHARTON & GARRISON LLP
PAUL, WEISS, RIFKIND, WHARTON & GARRISON LLP